Access the full text.
Sign up today, get DeepDyve free for 14 days.
P Sakthong, C Chinthammit, P Sukarnjanaset, N Sonsa-ardjit, W Munpan (2017)
Psychometric properties of the patient-reported outcomes measure of pharmaceutical therapy for quality of life (PROMPT-QoL)Value Health RI, 12C
Mohammed Mohammed, R. Moles, S. Hilmer, Lisa O’Donnel, T. Chen (2018)
Development and validation of an instrument for measuring the burden of medicine on functioning and well-being: the Medication-Related Burden Quality of Life (MRB-QoL) toolBMJ Open, 8
Mohammed Mohammed, R. Moles, T. Chen (2016)
Impact of Pharmaceutical Care Interventions on Health-Related Quality-of-Life OutcomesAnnals of Pharmacotherapy, 50
F. Ernst, A. Grizzle (2001)
Drug-related morbidity and mortality: updating the cost-of-illness model.Journal of the American Pharmaceutical Association, 41 2
P. Sakthong, C. Chinthammit, Pattarin Sukarnjanaset, Nontapat Sonsa-ardjit, Wipaporn Munpan (2017)
Psychometric Properties of the Patient-Reported Outcomes Measure of Pharmaceutical Therapy for Quality of Life (PROMPT-QOL).Value in health regional issues, 12
(2013)
Fundamental of biostatistics
J. Hanlon, C. Lindblad, S. Gray (2004)
Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults?The American journal of geriatric pharmacotherapy, 2 1
J. Krska, C. Morecroft, P. Rowe, H. Poole (2014)
Measuring the impact of long-term medicines use from the patient perspectiveInternational Journal of Clinical Pharmacy, 36
M. Machado, J. Bajcar, G. Guzzo, T. Einarson (2007)
Hypertenion: Sensitivity of Patient Outcomes to Pharmacist Interventions. Part II: Systematic Review and Meta-Analysis in Hypertension ManagementAnnals of Pharmacotherapy, 41
J. Krska, B. Katusiime, S. Corlett (2017)
Validation of an instrument to measure patients’ experiences of medicine use: the Living with Medicines QuestionnairePatient preference and adherence, 11
P. Sakthong, Phattrapa Suksanga, R. Sakulbumrungsil, Win Winit-Watjana (2015)
Development of Patient-reported Outcomes Measure of Pharmaceutical Therapy for Quality of Life (PROMPT-QoL): A novel instrument for medication management.Research in social & administrative pharmacy : RSAP, 11 3
P. Morley, L. Strand, R. Cipolle (2004)
Pharmaceutical Care Practice: The Clinician's Guide
F. Desplenter, S. Simoens, G. Laekeman (2007)
The impact of informing psychiatric patients about their medication: a systematic reviewPharmacy World and Science, 28
P. Sakthong, Todsaporn Sangthonganotai (2017)
A randomized controlled trial of the impact of pharmacist‐led patient‐centered pharmaceutical care on patients’ medicine therapy‐related quality of lifeResearch in Social and Administrative Pharmacy, 14
P. Sakthong, Nontapat Sonsa-ardjit, Pattarin Sukarnjanaset, Wipaporn Munpan (2015)
Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseasesQuality of Life Research, 24
W. Mclean, L. Mackeigan (2005)
When Does Pharmaceutical Care Impact Health Outcomes? A Comparison of Community Pharmacy—Based Studies of Pharmaceutical Care for Patients with AsthmaAnnals of Pharmacotherapy, 39
H. Tseng, Chia-Hui Lee, Yin-Jen Chen, Hsiang-Hao Hsu, L. Huang, Jing-Long Huang (2016)
Developing a measure of medication-related quality of life for people with polypharmacyQuality of Life Research, 25
J. Krska, C. Morecroft, H. Poole, P. Rowe (2013)
Issues potentially affecting quality of life arising from long-term medicines use: a qualitative studyInternational Journal of Clinical Pharmacy, 35
D. Malone, B. Carter, S. Billups, R. Valuck, D. Barnette, C. Sintek, G. Okano, S. Ellis, D. Covey, B. Mason, S. Jue, J. Carmichael, K. Guthrie, L. Sloboda, R. Dombrowski, D. Geraets, M. Amato (2001)
Can Clinical Pharmacists Affect SF-36 Scores in Veterans at High Risk for Medication-Related Problems?Medical Care, 39
M Machado, N Nassor, J Bajcar, GC Guzzo, TR Einarson (2008)
Part II: systemic review and meta-analysis in hyperlipidemia managementAnn Pharmacother, 42
C. Hepler, L. Strand (1990)
Opportunities and responsibilities in pharmaceutical care.American journal of hospital pharmacy, 47 3
M Machado, J Bajcar, GC Guzzo, TR Einarson (2007)
Sensitivity of patient outcomes to pharmacist interventions. Part II: systemic review and meta-analysis in hypertension managementAnn Pharmacother, 41
MA Mohammed, RJ Moles, TF Chen (2016)
Impact of pharmaceutical care interventions on health-related quality of life outcomes: a systemic review and meta-analysisAnn Pharmacother, 50
P. Lachenbruch (1989)
Statistical Power Analysis for the Behavioral Sciences (2nd ed.)Journal of the American Statistical Association, 84
R. Sitgreaves (1979)
Psychometric theory (2nd ed.).Psyccritiques, 24
JC Nunnally (1978)
Psychometric theory
Background The validated patient-reported outcomes measure of pharmaceutical therapy for quality of life (PROMPT-QoL) contains 43-items, and can be too lengthy for some applications. Objectives To develop a brief version called the PROMPT, and test its psychometric properties. Setting Four public hospitals in Bangkok, Thailand. Method Secondary analysis of three databases used to develop and evaluate the original PROMPT-QoL. Items for the short-form PROMPT were selected based on expert and patient evaluations of content and importance, and lack of redundancy. All domains of the original version are represented in the PROMPT. Main outcome measures Psychometric properties (internal consistency and test–retest reliability, criterion, convergent and discriminant validity, and responsiveness), and indicators of practicality (e.g., administration time, missing data). Results Analyses of the PROMPT and its domain subscales demonstrated good internal consistency and fair-to-excellent test–retest reliability. Correlations between the original and short-form, overall and by domain, were high. Expectations for convergent and discriminant validity were met as correlations between the PROMPT and generic health-related quality of life measures (WHOQoL-BREF domains and summary scores of the SF-12v2) were modest (< 0.40). Based on data from a trial of pharmaceutical care, the PROMPT short-form was very responsive to reductions in medication related problems. Administration time for the PROMPT is estimated to be about 5 min, and across all datasets used, no missing data were found amongst the 16 items of the PROMPT. Conclusion The 16-item PROMPT appears to be a practical, reliable, valid, and responsive instrument to identify patient’s drug-related needs and to assess the humanistic impact of patient-centered pharmaceutical care.
International Journal of Clinical Pharmacy – Springer Journals
Published: May 9, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.